Angela G. Brittsan, Ph.D. - Publications

Affiliations: 
2000 University of Cincinnati, Cincinnati, OH 
Area:
Pharmacology, Molecular Biology, Animal Physiology Biology

6/8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2003 Brittsan AG, Ginsburg KS, Chu G, Yatani A, Wolska BM, Schmidt AG, Asahi M, MacLennan DH, Bers DM, Kranias EG. Chronic SR Ca2+-ATPase inhibition causes adaptive changes in cellular Ca2+ transport. Circulation Research. 92: 769-76. PMID 12637367 DOI: 10.1161/01.Res.0000066661.49920.59  0.84
2001 Haghighi K, Schmidt AG, Hoit BD, Brittsan AG, Yatani A, Lester JW, Zhai J, Kimura Y, Dorn GW, MacLennan DH, Kranias EG. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. The Journal of Biological Chemistry. 276: 24145-52. PMID 11328820 DOI: 10.1074/Jbc.M102403200  0.84
2000 Brittsan AG, Kranias EG. Phospholamban and cardiac contractile function. Journal of Molecular and Cellular Cardiology. 32: 2131-9. PMID 11112989 DOI: 10.1006/Jmcc.2000.1270  0.84
2000 Brittsan AG, Carr AN, Schmidt AG, Kranias EG. Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban. The Journal of Biological Chemistry. 275: 12129-35. PMID 10766848 DOI: 10.1074/Jbc.275.16.12129  0.84
1999 Brittsan AG, Kiss E, Edes I, Grupp IL, Grupp G, Kranias EG. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions. Journal of Molecular and Cellular Cardiology. 31: 1725-37. PMID 10471356 DOI: 10.1006/Jmcc.1999.1010  0.84
1998 Kiss E, Brittsan AG, Edes I, Grupp IL, Grupp G, Kranias EG. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts. Circulation Research. 83: 608-13. PMID 9742056 DOI: 10.1161/01.Res.83.6.608  0.84
Low-probability matches
1998 Brittsan AG, Kadambi VJ, Hoit BD, Kranias EG. Cardiac overexpression of a non-phosphorylatable form of phospholamban results in depressed contractile function and hypertrophy Journal of Cardiac Failure. 4: 20. DOI: 10.1016/S1071-9164(98)90072-0  0.12
1999 Haghighi K, Hoi BD, Schmidt A, Kimura Y, Brittsan AG, MacLennan DH, Kranias EG. Cardiac overexpression of a mutant form of phospholamban is associated with depressed contractility and hypertrophy Journal of Cardiac Failure. 5: 11. DOI: 10.1016/S1071-9164(99)91386-6  0.04
Hide low-probability matches.